1[1]Stumvoll M, Hating MH. Glitazones: Clinical effects and molecular mechanisms[ J ]. Ann Med, 2002,34: 217.
2[2]Hallsten K, Virtanen KA, Lonnqvist F, et al. Rosiglitazone not metformin enhances insulin and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes[J ]. Diabetes,2002,51:3479.
3[3]Laurence IG. Rosiglitazone monotherapy and type 2 diabetes[ J ]. Diabet Med,2001,18: 6.
4[4]Werner AL, Travaglini MT. A review of rosiglitazone in type 2 diabetes mellitus[ J ]. Pharmacotherapy, 2001,21:1082.
5[5]Matthews DR. Guidance on rosiglitazone for type 2 diabetes mellitus[ J ]. Lancet,2001,357: 481.
6[6]Wagstaff AJ,Goa KL.Rosiglitazone:a review of its use in the management of type 2 diabetes mellitus [ J ]. Drugs,2002,62:1805.
7[7]A Diabetes Outcome Progression Trial( ADOPT) : an international multicenter study of the comparative efficacy of rosiglitazone,glyburide,and metformin in recently diagnosed type 2 diabetes [ J ] Diabetes Care, 2002, 25:1734.
8[8]Kreider M,Heise M. Rosiglitazone in the management of older patients with type 2 diabetes mellitus[J ]. Int J Clin Pract, 2002,56: 538.
9[9]Kiayias JA, Vlachon ED, Theodospoulou E, et al. Rosigilazone in combination with glimepiride plus metformin intype 2 diabetic patients [ J ]. Diabetes Care, 2002, 25:1251.
10[10]Gomez-Perrez FJ, Fanfhanel-Salmon G, Antonio-Barbose J, et al. Efficacy and safety of rosiglitazone plus metformin in mexicans with type 2 diabetes [ J ]. Diabetes Metab Res Rev,2002,18:127.
